TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TARS

Tarsus Pharmaceuticals Inc

Healthcare · Biotechnology

76.00$ +2.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow TARS
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-0.28 -0.19 -1.04 0.18 -1.99 -4.00 -2.21 -0.30
0.00 0.00 0.00 0.02 0.01 0.03 0.03 0.04
0.00 0.00 0.04 0.41 0.55 0.67 0.74 1.00
0.00 0.02 0.20 0.73 0.57 – – –
0.03 0.02 0.07 0.07 -0.04 0.01 0.10 0.35
0.00 0.01 0.02 0.03 0.02 0.19 0.04 0.24
0.00 -0.01 -0.02 -0.03 -5.87 4.79 -5.30 -1.01
– – 0.00 0.02 3.04 – – –
0.46 0.10 0.98 0.97 -0.04 0.34 1.99 0.00
0.83 3.05 6.48 0.00 3.82 4.43 4.11 3.43
0.55 2.85 5.42 0.15 -4.05 5.22 -3.39 2.13
-0.28 -0.20 -1.06 0.15 -2.01 -4.19 -2.25 -0.53

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?